A novel next-generation FVIIIa mimetic, Mim8, has a favorable safety profile and displays potent pharmacodynamic effects: Results from safety studies in cynomolgus monkeys.
J Thromb Haemost
; 20(6): 1312-1324, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35191180
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thrombosis
/
Hemophilia A
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Thromb Haemost
Journal subject:
HEMATOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Denmark
Country of publication:
United kingdom